Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model. [electronic resource]
Producer: 20160106Description: 43-51 p. digitalISSN:- 1096-1186
- Animals
- Biphenyl Compounds -- pharmacology
- Cardiotonic Agents -- pharmacology
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Cardiomyopathies -- drug therapy
- Endoplasmic Reticulum Stress -- drug effects
- Irbesartan
- Male
- Myocardium -- pathology
- Protein Kinase C -- antagonists & inhibitors
- Rats, Sprague-Dawley
- Tetrazoles -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.